Skip to main content

Pediatric Pathology Cancers

Edited by:

Shamlal Mangray, MB, BS, Nationwide Children’s Hospital, The Ohio State University College of Medicine, United States
 

Submission Status: Open   |   Submission Deadline: 12 June 2025


Wilms-2 tumor histologyDiagnostic Pathology is calling for submissions to our Collection on Pediatric Pathology Cancers. This Collection invites original research articles and reviews aiming to enhance our understanding of childhood cancers.



Image credit: © Shamlal Mangray

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

Meet the Guest Editor

Back to top

Shamlal Mangray, MB, BS, Nationwide Children’s Hospital, The Ohio State University College of Medicine, United States

Profile photograph Shamlal MangrayDr Shamlal Mangray is the Chief of Pathology and Laboratory Medicine at Nationwide Children’s Hospital and Professor of Clinical Pathology at The Ohio State University College of Medicine, Columbus, OH. His medical training was at the University of the West Indies, residency training at Brown University, Providence, RI and fellowships in Surgical Pathology at Vanderbilt University, Nashville, TN and Pediatric Pathology at Brown. As faculty at Brown, he served in leadership roles in Autopsy and Pediatric Pathology, and the Residency Training Program. His areas of interests include diagnostic pediatric pathology, endocrine pathology and GI pathology.

About the Collection

Wilms-2 tumor histologyDiagnostic Pathology is calling for submissions to our Collection on Pediatric Pathology Cancers. The field of pediatric pathology is vital for understanding cancers in children, who face unique diagnostic and treatment challenges. As we explore the relationship between pathology and pediatric cancers, it is essential to enhance our knowledge of the mechanisms, morphological features, and molecular profiles that characterize these malignancies. This understanding not only improves diagnostics but also informs prognosis and tailored therapeutic strategies for young patients.

Recent advances have refined our approach to pediatric cancers. The integration of immunohistochemistry and molecular techniques has enabled precise tumor characterization, leading to better prognostic assessments and targeted therapies. Identifying specific biomarkers allows clinicians to stratify patients by risk, ensuring that those needing aggressive treatment receive it while sparing others from unnecessary interventions. Furthermore, advancements in imaging technologies and digital pathology have improved diagnostic accuracy and communication among healthcare providers, ultimately enhancing patient care.

Looking ahead, continued research in pediatric pathology holds the promise of more groundbreaking advancements. We may see further developments in personalized medicine approaches that utilize genetic profiling to tailor treatments to individual patients, thereby minimizing side effects and maximizing efficacy. Additionally, the integration of artificial intelligence and machine learning in pathology could revolutionize diagnostic processes, allowing for faster and more accurate identification of malignancies.

This Collection invites original research articles and reviews, covering research including but not limited to the following topics:

•    Morphological Features of Pediatric Neoplasms
•    Advances in Immunohistochemistry Techniques in Childhood Tumors
•    Molecular Pathology of Pediatric Tumors
•    The Role of Genetics in Pediatric Tumor Development
•    Prognostic Markers in Childhood Cancers
•    Digital Pathology in Pediatric Cancer Diagnosis
•    Artificial Intelligence Applications in Pediatric Cancer Diagnosis
•    Radiology-Pathology Correlation in Childhood Cancers
•    Telepathology in Pediatric Cancer Diagnosis
•    Application of Pathology for Novel Therapeutic Approaches for Childhood Cancers


Image credit: © Shamlal Mangray

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original research articles and reviews. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Pediatric Pathology Cancers" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.